Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seaman

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Case Reports in Obstetrics and Gynecology|March 14, 2022
Management of a Novel Autoimmune Disease, COPA Syndrome, in PregnancyArchana Ayyar, Rachel D Seaman, Kalpalatha Guntupalli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 21, 2019
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitorsPatrick T Ebbert, Frederico Xavier, Craig D Seaman, et al.
Thrombosis Research|June 15, 2016
Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities StudyCraig D Seaman, Kristen M George, Margaret Ragni, et al.
Journal of Thrombosis and Haemostasis : JTH|September 15, 2015
Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge registerC D Seaman, J Yabes, D M Comer, et al.
Pilot and Feasibility Studies|December 9, 2020
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndromeCraig D Seaman, Enrico Novelli, Laura De Castro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 crossover trialCraig D Seaman, Jonathan G Yabes, Christina M Lalama, et al.
Thrombosis Research|October 13, 2014
Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysisCraig D Seaman, Jonathan Yabes, Jie Li, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 7, 2016
Prevalence and Risk Factors Associated With Hypertension in Hemophilia: Cross-Sectional Analysis of a National Discharge RegisterCraig D Seaman, Mariya Apostolova, Jonathan Yabes, et al.
Thrombosis Research|July 13, 2020
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia APatrick T Ebbert, Frederico Xavier, Lynn M Malec, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 23, 2016
Prevalence and Risk Factors Associated With Hypertension in von Willebrand DiseaseMariya H Apostolova, Craig D Seaman, Diane M Comer, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Case Reports in Obstetrics and Gynecology|March 14, 2022
Management of a Novel Autoimmune Disease, COPA Syndrome, in PregnancyArchana Ayyar, Rachel D Seaman, Kalpalatha Guntupalli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 21, 2019
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitorsPatrick T Ebbert, Frederico Xavier, Craig D Seaman, et al.
Thrombosis Research|June 15, 2016
Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities StudyCraig D Seaman, Kristen M George, Margaret Ragni, et al.
Journal of Thrombosis and Haemostasis : JTH|September 15, 2015
Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge registerC D Seaman, J Yabes, D M Comer, et al.
Pilot and Feasibility Studies|December 9, 2020
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndromeCraig D Seaman, Enrico Novelli, Laura De Castro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 crossover trialCraig D Seaman, Jonathan G Yabes, Christina M Lalama, et al.
Thrombosis Research|October 13, 2014
Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysisCraig D Seaman, Jonathan Yabes, Jie Li, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 7, 2016
Prevalence and Risk Factors Associated With Hypertension in Hemophilia: Cross-Sectional Analysis of a National Discharge RegisterCraig D Seaman, Mariya Apostolova, Jonathan Yabes, et al.
Thrombosis Research|July 13, 2020
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia APatrick T Ebbert, Frederico Xavier, Lynn M Malec, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 23, 2016
Prevalence and Risk Factors Associated With Hypertension in von Willebrand DiseaseMariya H Apostolova, Craig D Seaman, Diane M Comer, et al.
Pageof 4